Monday, January 18, 2021

$37.63 Million in Sales Expected for Sangamo Therapeutics, Inc. (NASDAQ:SGMO) This Quarter

... genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation.
https://www.google.com/url?rct=j&sa=t&url=https://www.marketbeat.com/instant-alerts/nasdaq-sgmo-consensus-analyst-rating-2021-01/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNE1FZpitCvxpjma1WdRFSvccX0hGw
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...